StockNews.com began coverage on shares of Quest Diagnostics ( NYSE:DGX – Get Rating ) in a research note released on Thursday. The firm issued a hold rating on the medical research company's stock. Other equities research analysts have also recently issued reports about the company. Mizuho reiterated a buy rating and issued a $165.00 price objective on shares of Quest Diagnostics in a report on Friday, March 17th. Citigroup raised Quest Diagnostics from a sell rating to a neutral rating and boosted their price objective for the stock from $125.

https://www.dailypolitical.com/2023/05/22/quest-diagnostics-nysedgx-research-coverage-started-at-stocknews-com.html

#dailypolitical